Autolus Therapeutics to Release Fourth Quarter 2024 Results
Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering biopharmaceutical company known for its advanced T cell therapies, is set to announce its financial results for the fourth quarter and full year of 2024. This crucial update will be made public before the stock market opens on Thursday, March 20, 2025.
Conference Call to Discuss Financial Performance
The management team of Autolus will host a conference call and webcast at 8:30 AM EDT / 12:30 PM GMT to present the financial results and share significant operational insights. For those interested in participating, it is advised to pre-register to obtain the necessary dial-in information and personal PIN required for access to the call.
Accessing the Audio Webcast
Alongside the conference call, there will be a simultaneous audio webcast for those who prefer to listen online. A replay will also be available, making it convenient for stakeholders who may have missed the live event. Participants can find the audio session on the events section of Autolus' official website.
Understanding Autolus Therapeutics
As an innovative leader in the biopharmaceutical sector, Autolus Therapeutics focuses on developing advanced T cell therapies designed to target and treat various forms of cancer as well as autoimmune diseases. By employing their unique T cell programming technologies, they are creating therapies aimed at effectively identifying and dismantling the defenses of harmful cells in the body.
Key Products and Pipeline
Autolus is proud to have an FDA-approved product known as AUCATZYL, which is already making waves in the medical community. The company is also diligently working on a pipeline that includes several product candidates focused on treating hematological malignancies, solid tumors, and autoimmune disorders, showcasing their commitment to tackling complex health challenges.
Contact Information for Inquiries
For any inquiries regarding the upcoming financial results or corporate updates, individuals can reach out to:
Amanda Cray
+1 617-967-0207
a.cray@autolus.com
Olivia Manser
+44 7780 471 568
o.manser@autolus.com
Frequently Asked Questions
When will Autolus release its fourth quarter results?
Autolus Therapeutics will release its fourth quarter and full year 2024 financial results on March 20, 2025, before US markets open.
What time is the conference call?
The conference call is scheduled for 8:30 AM EDT / 12:30 PM GMT on the day of the financial results announcement.
How can I access the audio webcast?
The audio webcast can be accessed through the events section on Autolus' official website.
What is the primary focus of Autolus Therapeutics?
Autolus Therapeutics specializes in the development of next-generation T cell therapies aimed at treating cancer and autoimmune diseases.
Who should I contact for more information?
For further inquiries, contact Amanda Cray or Olivia Manser as provided in the announcement.